Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Premier Research has added of Cassandra Matney, M.D., as Senior Medical Director.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Raremark® has launched its patient-powered knowledge platform Xperiome™ to help the pharmaceutical industry deliver innovative new therapies faster and smarter.
read more
Adicet Bio has received a $10 million milestone payment from Regeneron associated with ADI-002 meeting key preclinical development goals.
read more
CluePoints announced the success of its complimentary COVID-19 risk management package alongside comprehensive support for COVID-19 affected trials.
read more
Cryoport and Medipal Holdings announced a multi-year strategic business alliance agreement to create an integrated regenerative medicine supply chain solution in Japan.
read more
PharmaLex Group has added Sébastien Schmitt to the company’s senior management team.
read more
VistaGen Therapeutics announced receipt of a $5 million non-dilutive upfront license payment from EverInsight Therapeutics.
read more
Horizon Discovery Group has announced the addition of single cell RNAseq-linked pooled CRISPR screening to its CRISPR screening services portfolio.
read more
Clinical Ink announced its acquisition by GI Partners, a private equity investment firm.
read more
Catalent will expand its Argentinian site in Loma Hermosa, Buenos Aires.
read more
CRL has received EUA and is scaling up capacity for CRL Rapid Response, a saliva-based COVID-19 RT-PCR test that can be self-collected.
read more
Otonomy announced a license agreement with KYORIN that provides exclusive worldwide rights to develop, manufacture and commercialize a novel compound for sensorineural hearing loss.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more